We are live on ! Find out more
SAMH

Shanda Asset Management Holdings Portfolio holdings

AUM $1.85B
1-Year Est. Return 36.09%
This Fund
S&P 500
This Quarter Est. Return
-26.63%
1 Year Est. Return
+36.09%
3 Year Est. Return
+114.94%
5 Year Est. Return
-33.67%
10 Year Est. Return
-25.97%
AUM
$535M
AUM Growth
-$86.8M
Cap. Flow
+$93.7M
Cap. Flow %
17.52%
Top 10 Hldgs %
87.3%
Holding
60
New
22
Increased
11
Reduced
–
Closed
10

Top Buys

Rank Stock Value
1
CLDR
Cloudera, Inc.
CLDR
+$15.8M
2
CAR icon
Avis
CAR
+$11.9M
3
AMZN icon
Amazon
AMZN
+$9.98M
4
BLK icon
Blackrock
BLK
+$9.1M
5
BX icon
Blackstone
BX
+$7.64M

Top Sells

Rank Stock Value
1
AMBA icon
Ambarella
AMBA
+$7.74M
2
W icon
Wayfair
W
+$3.69M
3
MB
MINDBODY, Inc. Class A Common Stock
MB
+$2.44M
4
XOM icon
ExxonMobil
XOM
+$1.85M
5
COHR
Coherent Inc
COHR
+$1.02M

Sector Composition

Rank Sector Weight
1 Financials 62.34%
2 Healthcare 17.18%
3 Technology 5.44%
4 Communication Services 5.28%
5 Industrials 3.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCC icon
26
Ares Capital
ARCC
$14.4B
$1.6M 0.3%
103,030
– –
GSKY
27
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$1.52M 0.28%
+158,427
New +$1.85M
WDC icon
28
Western Digital
WDC
$150B
$1.48M 0.28%
52,920
+26,460
+100% +$938K
SGMO
29
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.31M 0.25%
+114,410
New +$1.42M
ELLI
30
DELISTED
Ellie Mae Inc
ELLI
$1.26M 0.24%
+20,000
New +$1.42M
EDIT icon
31
Editas Medicine
EDIT
$442M
$1.22M 0.23%
+53,579
New +$1.46M
VNDA icon
32
Vanda Pharmaceuticals
VNDA
$302M
$1.17M 0.22%
44,787
– –
INST
33
DELISTED
Instructure, Inc.
INST
$1.13M 0.21%
+30,000
New +$1.06M
IQV icon
34
IQVIA
IQV
$39.3B
$1.07M 0.2%
+9,224
New +$1.12M
PTCT icon
35
PTC Therapeutics
PTCT
$6.12B
$1.04M 0.19%
30,332
– –
TVRD
36
Tvardi Therapeutics
TVRD
$23.4M
$715K 0.13%
1,527
– –
NBIX icon
37
Neurocrine Biosciences
NBIX
$16.6B
$714K 0.13%
10,000
– –
NTLA icon
38
Intellia Therapeutics
NTLA
$1.67B
$664K 0.12%
+48,657
New +$904K
LH icon
39
Labcorp
LH
$25.9B
$586K 0.11%
+5,396
New +$723K
ACOR
40
DELISTED
Acorda Therapeutics
ACOR
$404K 0.08%
216
– –
ITCI
41
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$402K 0.08%
35,278
– –
ZGNX
42
DELISTED
Zogenix, Inc.
ZGNX
$365K 0.07%
10,000
– –
SUPN icon
43
Supernus Pharmaceuticals
SUPN
$2.77B
$332K 0.06%
10,000
– –
ICLR icon
44
Icon
ICLR
$12.7B
$323K 0.06%
+2,499
New +$345K
PRAH
45
DELISTED
PRA Health Sciences, Inc.
PRAH
$274K 0.05%
+2,980
New +$302K
CRL icon
46
Charles River Laboratories
CRL
$12.8B
$250K 0.05%
+2,207
New +$276K
SYNH
47
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$186K 0.03%
+4,735
New +$220K
MEDP icon
48
Medpace
MEDP
$16.5B
$87K 0.02%
+1,638
New +$89.9K
AXSM icon
49
Axsome Therapeutics
AXSM
$10.9B
$56K 0.01%
19,958
– –
MRNS
50
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$29K 0.01%
2,500
– –
1
2
3

Similar funds

DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
OFG
Oxford Financial Group Carmel, Indiana $1.86B AUM 19.25% 1-Year Est. Return
CFA
Capstone Financial Advisors Downers Grove, Illinois $1.86B AUM 15.98% 1-Year Est. Return

Shanda Asset Management Holdings's Q4 2018 Portfolio in Review

As of Q4 2018, Shanda Asset Management Holdings held 60 positions worth $535M, down 14% from $621M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Shanda Asset Management Holdings deployed $93.7M of net new capital in Q4 2018, opening 22 new positions and adding to 11 existing holdings. Its largest new stake was Amazon: 120,000 shares worth $9.01M.

By sector, the portfolio is most concentrated in Financials at 62% of assets, down from 71% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the most notable exit was Ambarella, an estimated $7.74M sold.

  • Shanda Asset Management Holdings's largest Q4 2018 buy was Amazon: 120,000 shares worth $9.01M.
  • Shanda Asset Management Holdings added most to Cloudera, Inc. in Q4 2018, an estimated $15.8M increase.
  • Shanda Asset Management Holdings fully exited Ambarella in Q4 2018, selling an estimated $7.74M.
  • Shanda Asset Management Holdings's ten largest holdings make up 87% of its $535M portfolio in Q4 2018.
  • Shanda Asset Management Holdings opened 22 new positions and closed 10 in Q4 2018.
  • Shanda Asset Management Holdings's portfolio value fell 14% quarter-over-quarter to $535M.

Based on Shanda Asset Management Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.